康方生物(09926.HK)委任謝榕剛為非執行董事
格隆匯 8 月 19日丨康方生物(09926.HK)公告,林利軍(為正心谷資本合夥人)因有其他個人事務需要投入更多精力及時間處理,故已辭任非執行董事,自2020年8月19日起生效。
進一步宣佈,委任謝榕剛(目前擔任正心谷資本的董事總經理)為非執行董事,自2020年8月19日生效。
謝榕剛,35歲,有約10年投資經驗。謝榕剛分別於2008年及2011年獲得中國東南大學生物醫學工程學士學位及碩士學位。謝榕剛於2011年4月至2015年10月期間於元禾控股工作,並自2018年起擔任正心谷資本的董事總經理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.